|
EP0810853B1
(en)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Aerosols containing nanoparticle dispersions
|
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
|
US20080102121A1
(en)
*
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
HUP0300491A2
(en)
*
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
GB0009773D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
DE10043509A1
(de)
*
|
2000-09-01 |
2002-03-14 |
Asta Medica Ag |
Feste Peptidzubereitungen für die Inhalation und deren Herstellung
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US7998507B2
(en)
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
DE10058772A1
(de)
*
|
2000-11-27 |
2002-06-06 |
Falk Pharma Gmbh |
Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
|
|
JP4380988B2
(ja)
*
|
2000-11-30 |
2009-12-09 |
ヴェクトゥラ リミテッド |
医薬組成物に用いられる粒子の製造方法
|
|
AU2002215114A1
(en)
*
|
2000-11-30 |
2002-06-11 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
|
EP1337239B2
(en)
*
|
2000-11-30 |
2015-11-25 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
|
ES2587135T3
(es)
*
|
2000-11-30 |
2016-10-20 |
Vectura Limited |
Procedimiento de fabricación de partículas para su uso en una composición farmacéutica
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
|
PT1372608E
(pt)
*
|
2001-03-30 |
2008-01-04 |
Jagotec Ag |
Formulações de aerossol médicas
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
|
WO2002094242A1
(en)
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
|
WO2002094229A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of muscle relaxants through an inhalation route
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
DE60230609D1
(de)
*
|
2001-05-24 |
2009-02-12 |
Alexza Pharmaceuticals Inc |
Verabreichung von nichtsteroidalen entzündungshemmenden wirkstoffen durch inhalation
|
|
NZ529417A
(en)
|
2001-05-24 |
2006-11-30 |
Alexza Pharmaceuticals Inc |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
ES2280582T3
(es)
*
|
2001-09-19 |
2007-09-16 |
Elan Pharma International Limited |
Formulaciones de insulina en nanoparticulas.
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
CN1558755A
(zh)
|
2001-09-26 |
2004-12-29 |
���ع��ʹ�˾ |
通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
WO2003041693A1
(en)
|
2001-11-09 |
2003-05-22 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
|
AU2002364701B8
(en)
*
|
2001-11-20 |
2006-06-22 |
Alkermes, Inc. |
Compositions for sustained action product delivery
|
|
EP1446102A1
(en)
|
2001-11-21 |
2004-08-18 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
SI3494995T1
(sl)
|
2002-03-01 |
2020-08-31 |
Chiesi Farmaceutici S.P.A. |
Superfina formulacija formoterola
|
|
ATE343376T1
(de)
*
|
2002-03-20 |
2006-11-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
|
US20030185762A1
(en)
*
|
2002-03-22 |
2003-10-02 |
Cowan Siu Man L. |
Highly aqueous liquid carrier formulations
|
|
GB0219815D0
(en)
*
|
2002-08-24 |
2002-10-02 |
Accentus Plc |
Preparation of small crystals
|
|
FI20020857A7
(fi)
*
|
2002-05-07 |
2003-11-08 |
Focus Inhalation Oy |
Amorfisen aineen muuntaminen vastaavaksi kiteiseksi aineeksi spraykuivaamalla ja käyttämällä kiteistä spraykuivattua ainetta lääkevalmisteissa
|
|
WO2003105775A2
(en)
*
|
2002-06-17 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
AU2003279493B2
(en)
|
2002-10-25 |
2009-08-20 |
Foamix Pharmaceuticals Ltd. |
Cosmetic and pharmaceutical foam
|
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
JP4707937B2
(ja)
*
|
2003-02-28 |
2011-06-22 |
ホソカワミクロン株式会社 |
薬物含有複合粒子の製造方法および経肺製剤
|
|
US7811606B2
(en)
*
|
2003-04-16 |
2010-10-12 |
Dey, L.P. |
Nasal pharmaceutical formulations and methods of using the same
|
|
US8912174B2
(en)
|
2003-04-16 |
2014-12-16 |
Mylan Pharmaceuticals Inc. |
Formulations and methods for treating rhinosinusitis
|
|
US9808471B2
(en)
*
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
ATE510174T1
(de)
|
2003-05-21 |
2011-06-15 |
Alexza Pharmaceuticals Inc |
Schlag gezündete unabhängige heizeinheit
|
|
CA2523035C
(en)
*
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
US7109247B2
(en)
|
2003-05-30 |
2006-09-19 |
3M Innovative Properties Company |
Stabilized particle dispersions containing nanoparticles
|
|
US7459146B2
(en)
*
|
2003-05-30 |
2008-12-02 |
3M Innovative Properties Company |
Stabilized aerosol dispersions
|
|
US20040242729A1
(en)
*
|
2003-05-30 |
2004-12-02 |
3M Innovative Properties Company |
Stabilized particle dispersions containing surface-modified inorganic nanoparticles
|
|
DE10325989A1
(de)
*
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
|
EP1632225A4
(en)
*
|
2003-06-11 |
2007-08-15 |
Nara Machinery Co Ltd |
DRUG NANOPARTICLE, PROCESS AND APPARATUS FOR PREPARING PHARMACEUTICAL PREPARATION THEREFROM
|
|
WO2004112799A1
(en)
*
|
2003-06-13 |
2004-12-29 |
Chrysalis Technologies Incorporated |
Methods and apparatus for producing nanoscale particles
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
|
US20060292081A1
(en)
*
|
2003-09-15 |
2006-12-28 |
Vectura Limited |
Methods for preparing pharmaceutical compositions
|
|
US20060263350A1
(en)
*
|
2003-09-26 |
2006-11-23 |
Fairfield Clinical Trials Llc |
Combination antihistamine medication
|
|
GB0323684D0
(en)
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
WO2005077339A1
(en)
*
|
2004-02-10 |
2005-08-25 |
E.I. Dupont De Nemours And Company |
Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
|
|
WO2005084710A2
(en)
*
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
US20070053845A1
(en)
*
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
WO2005110379A2
(en)
*
|
2004-05-07 |
2005-11-24 |
President And Fellows Of Harvard College |
Pulmonary malarial vaccine
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
US20060009435A1
(en)
*
|
2004-06-23 |
2006-01-12 |
Joseph Kaspi |
Synthesis and powder preparation of fluticasone propionate
|
|
AU2004322756B2
(en)
|
2004-08-12 |
2011-04-14 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
|
GB0418791D0
(en)
|
2004-08-23 |
2004-09-22 |
Glaxo Group Ltd |
Novel process
|
|
EP1789018A1
(en)
|
2004-08-27 |
2007-05-30 |
The Dow Chemical Company |
Enhanced delivery of drug compositions to treat life threatening infections
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
BRPI0517374A
(pt)
|
2004-10-29 |
2008-10-07 |
Harvard College |
formulação para tratamento ou prevenção de infecção respiratória, método para tratamento
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
GB0426301D0
(en)
*
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
SG161203A1
(en)
*
|
2004-12-15 |
2010-05-27 |
Elan Pharma Int Ltd |
Nanoparticulate tacrolimus formulations
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
|
EA013433B1
(ru)
*
|
2005-02-15 |
2010-04-30 |
Элан Фарма Интернэшнл Лтд. |
Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
JP2008533157A
(ja)
*
|
2005-03-14 |
2008-08-21 |
マサチューセッツ・インスティテュート・オブ・テクノロジー |
疾患および障害の診断および処置のためのナノセル
|
|
US20070065374A1
(en)
*
|
2005-03-16 |
2007-03-22 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
|
EA200701997A1
(ru)
*
|
2005-03-17 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиция из наночастиц бисфосфоната
|
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
|
US20090081297A1
(en)
*
|
2005-04-27 |
2009-03-26 |
Cook Robert O |
Use of surface tension reducing agents in aerosol formulations
|
|
EP1954253A4
(en)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
|
|
US7947308B2
(en)
*
|
2005-07-20 |
2011-05-24 |
Raimar Loebenberg |
Effervescent powders for inhalation
|
|
JP2007079857A
(ja)
*
|
2005-09-13 |
2007-03-29 |
Canon Inc |
サーバー装置、クライアント装置及びそれらの制御方法、コンピュータプログラム、記憶媒体
|
|
EP1933814A2
(en)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
|
EP1954246A4
(en)
*
|
2005-11-11 |
2012-01-18 |
Biolab Sanus Farmaceutica Ltda |
SOLID PHARMACEUTICAL COMPOSITION WITH AGGLOMERATE NANOTEILES AND MANUFACTURING METHOD THEREFOR
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
WO2007076295A2
(en)
*
|
2005-12-16 |
2007-07-05 |
University Of Kansas |
Nanoclusters for delivery of therapeutics
|
|
EP1798504A1
(en)
*
|
2005-12-19 |
2007-06-20 |
Koninklijke Philips Electronics N.V. |
Method of making dried particles
|
|
US20070178051A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
US20070202182A1
(en)
*
|
2006-02-26 |
2007-08-30 |
Kane Kevin M |
Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
FI20060428L
(fi)
*
|
2006-05-03 |
2007-11-04 |
Esko Kauppinen |
Pintamodifioidut aerosolihiukkaset, menetelmä ja laite niiden tuottamiseksi sekä jauheet ja dispersiot jotka sisältävät kyseisiä hiukkasia
|
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
DK2054042T3
(da)
|
2006-06-30 |
2020-08-03 |
Iceutica Pty Ltd |
Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
JP2010515753A
(ja)
|
2007-01-10 |
2010-05-13 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
肺内送達用免疫抑制剤組成物の送達の増強
|
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
JP2008222567A
(ja)
*
|
2007-03-08 |
2008-09-25 |
Iwate Univ |
微粒子の製造方法
|
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
WO2008131170A1
(en)
|
2007-04-18 |
2008-10-30 |
Particle Sciences, Inc, |
Aerosol dispersions of particles with active pharmaceutical ingredients
|
|
EP2155166A2
(en)
*
|
2007-05-11 |
2010-02-24 |
F. Hoffmann-Roche AG |
Pharmaceutical compositions for poorly soluble drugs
|
|
GB0712454D0
(en)
*
|
2007-06-27 |
2007-08-08 |
Generics Uk Ltd |
Pharmaceutical compositions
|
|
WO2009020434A1
(en)
*
|
2007-08-07 |
2009-02-12 |
Nanomaterials Technology Pte Ltd |
A process for making micro-sized protein particles
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009049159A1
(en)
|
2007-10-10 |
2009-04-16 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
|
CA2702261A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Map Pharmaceuticals, Inc. |
Inhalation drug delivery
|
|
EP3424525A1
(en)
|
2007-10-12 |
2019-01-09 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
|
US20110142914A1
(en)
*
|
2007-12-06 |
2011-06-16 |
Cytotech Labs, Llc |
Inhalable compositions having enhanced bioavailability
|
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
DK2230934T3
(da)
|
2007-12-14 |
2012-11-26 |
Aerodesigns Inc |
Afgivelse af aerosoliserbare næringsmiddelprodukter
|
|
EP2242476A2
(en)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
EP2095816A1
(en)
*
|
2008-02-29 |
2009-09-02 |
Schlichthaar, Rainer, Dr. |
Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety
|
|
WO2009117410A2
(en)
*
|
2008-03-17 |
2009-09-24 |
Board Of Regents, The University Of Texas System |
Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques
|
|
US9956170B2
(en)
*
|
2008-06-26 |
2018-05-01 |
3M Innovative Properties Company |
Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
KR20100052262A
(ko)
*
|
2008-11-10 |
2010-05-19 |
(주)아모레퍼시픽 |
난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에의해 제조된 분말 및 이를 포함하는 약학적 조성물
|
|
US20100119558A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Scandivir Ab |
Ngna compositions and methods of use
|
|
US9028878B2
(en)
|
2009-02-03 |
2015-05-12 |
Microbion Corporation |
Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
|
|
US8389021B2
(en)
|
2009-02-03 |
2013-03-05 |
Microbion Corporation |
Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
|
|
PL3578169T3
(pl)
|
2009-02-26 |
2024-09-02 |
Glaxo Group Limited |
Preparaty farmaceutyczne zawierające 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
|
|
US8685458B2
(en)
|
2009-03-05 |
2014-04-01 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives
|
|
CN102458380A
(zh)
*
|
2009-04-24 |
2012-05-16 |
先灵公司 |
包含具有目的颗粒大小的活性药物试剂的团聚体制剂
|
|
BRPI1014275B8
(pt)
|
2009-04-24 |
2021-05-25 |
Iceutica Pty Ltd |
composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos
|
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
CN107252482A
(zh)
|
2009-05-27 |
2017-10-17 |
西莱克塔生物科技公司 |
具有不同释放速率的纳米载体加工组分
|
|
US20100310660A1
(en)
*
|
2009-06-08 |
2010-12-09 |
Taipei Medical University |
Dry powder microparticles for pulmonary delivery
|
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
US20110033545A1
(en)
*
|
2009-08-06 |
2011-02-10 |
Absize, Inc. |
Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
MX359879B
(es)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Composiciones tópicas de tetraciclina.
|
|
GB0918149D0
(en)
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
GB201001070D0
(en)
|
2010-01-22 |
2010-03-10 |
St George's Hospital Medical School |
Theraputic compounds and their use
|
|
PT2544663T
(pt)
|
2010-03-12 |
2018-04-05 |
Berg Llc |
Formulações intravenosas de coenzima q10 (coq10) e métodos de uso da mesma
|
|
EP2560624B1
(en)
|
2010-04-23 |
2018-07-04 |
KemPharm, Inc. |
Therapeutic formulation for reduced drug side effects
|
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
|
WO2011150258A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
GB201011411D0
(en)
|
2010-07-06 |
2010-08-18 |
St Georges Hosp Medical School |
Therapeutic compounds and their use
|
|
US8815294B2
(en)
|
2010-09-03 |
2014-08-26 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives and a carrier material
|
|
EP2618818A4
(en)
*
|
2010-09-22 |
2014-10-29 |
Map Pharmaceuticals Inc |
CORTICOSTEROID PARTICLES AND METHOD FOR PRODUCING THE SAME
|
|
EP2627317A4
(en)
*
|
2010-10-15 |
2014-08-20 |
Glaxo Group Ltd |
MEDICINAL FORMULATIONS FROM AGGREGATED NANOPARTICLES AND THEIR PREPARATION AND USE
|
|
JOP20120023B1
(ar)
|
2011-02-04 |
2022-03-14 |
Novartis Ag |
صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
|
|
GB201102237D0
(en)
*
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
CN103391769A
(zh)
|
2011-02-17 |
2013-11-13 |
霍夫曼-拉罗奇有限公司 |
通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法
|
|
US9084727B2
(en)
|
2011-05-10 |
2015-07-21 |
Bend Research, Inc. |
Methods and compositions for maintaining active agents in intra-articular spaces
|
|
JO3410B1
(ar)
*
|
2011-06-07 |
2019-10-20 |
Otsuka Pharma Co Ltd |
تركيبة أريبيبرازول مجفف بالتبريد
|
|
US8945605B2
(en)
*
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
CA2838529C
(en)
|
2011-06-07 |
2020-03-24 |
Parion Sciences, Inc. |
Methods of treatment
|
|
AU2012271274B2
(en)
|
2011-06-17 |
2017-07-27 |
Berg Llc |
Inhalable pharmaceutical compositions
|
|
US20130028857A1
(en)
|
2011-07-29 |
2013-01-31 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
|
|
WO2013059676A1
(en)
*
|
2011-10-21 |
2013-04-25 |
Subhash Desai |
Compositions for reduction of side effects
|
|
EP2601973A1
(en)
|
2011-12-09 |
2013-06-12 |
Laboratoires SMB SA |
Dry powder formulation of azole derivative for inhalation
|
|
EP2814558A4
(en)
*
|
2012-02-16 |
2015-08-19 |
Capnia Inc |
GAS DISTRIBUTOR WITH A SPREADING MOUTHPIECE
|
|
BR112014025518B1
(pt)
*
|
2012-04-13 |
2022-05-24 |
Glaxosmithkline Intellectual Property Development Limited |
Partículas agregadas de umeclidinium, vilanterol e fluticasona, composição em pó, inalador, processo para a preparação de partículas agregadas, e, uso de estearato de magnésio em partículas agregadas
|
|
MX2015005556A
(es)
*
|
2012-11-01 |
2015-11-13 |
Precision Valve Corp |
Valvula de aerosol de flujo libre.
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
GB201307659D0
(en)
*
|
2013-04-26 |
2013-06-12 |
Korea Coast Guard Commissioner |
Preparation of drug particles by micronisation
|
|
CA2910766C
(en)
|
2013-04-30 |
2020-12-15 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
|
WO2015089105A1
(en)
|
2013-12-09 |
2015-06-18 |
Respira Therapeutics, Inc. |
Pde5 inhibitor powder formulations and methods relating thereto
|
|
CN112656780A
(zh)
|
2014-02-20 |
2021-04-16 |
奥迪托皮克股份有限公司 |
用于吸入的干粉制剂
|
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
|
EP3302423B1
(en)
|
2015-06-04 |
2022-05-25 |
Crititech, Inc. |
Particle production system and particle collection device
|
|
WO2017176628A1
(en)
|
2016-04-04 |
2017-10-12 |
Crititech, Inc. |
Methods for solid tumor treatment
|
|
GB201609925D0
(en)
*
|
2016-06-07 |
2016-07-20 |
Novabiotics Ltd |
Formulation
|
|
CA2978573A1
(en)
|
2016-09-08 |
2018-03-08 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
|
BR112019023948A2
(pt)
|
2017-06-09 |
2020-06-09 |
Crititech Inc |
tratamento de cistos epiteliais por injeção intracística de partículas antineoplásicas
|
|
EP3615004B1
(en)
|
2017-06-14 |
2025-02-19 |
Crititech, Inc. |
Methods for treating lung disorders
|
|
JP7792750B2
(ja)
|
2017-10-03 |
2025-12-26 |
クリティテック・インコーポレイテッド |
癌の治療のための免疫療法剤の全身送達と組み合わせた抗腫瘍粒子の局所送達
|
|
US11534397B2
(en)
*
|
2017-11-09 |
2022-12-27 |
The Board Of Regents Of The University Of Oklahoma |
Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof
|
|
WO2019126703A1
(en)
|
2017-12-22 |
2019-06-27 |
Ecolab Usa Inc. |
Antimicrobial compositions with enhanced efficacy
|
|
US12214118B2
(en)
|
2018-02-02 |
2025-02-04 |
Alexza Pharmaceuticals, Inc. |
Electrical condensation aerosol device
|
|
CN108651937B
(zh)
*
|
2018-04-20 |
2021-12-24 |
大连工业大学 |
一种基于超声波喷雾冷冻干燥生产高汤调味粉的方法
|
|
BR112020022294A2
(pt)
|
2018-05-04 |
2021-02-23 |
Tollys |
composição e uso de uma composição
|
|
MX2021000796A
(es)
*
|
2018-07-24 |
2021-06-15 |
Univ Texas |
Composiciones de partículas terapéuticamente activas con superficie modificada por congelación ultra-rápida.
|
|
MX2021001272A
(es)
*
|
2018-07-31 |
2021-07-15 |
Microbion Corp |
Composiciones de bismuto-tiol y metodos de uso.
|
|
MX2021001276A
(es)
|
2018-07-31 |
2021-07-15 |
Microbion Corp |
Composiciones de bismuto-tiol y metodos para tratar heridas.
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
EP4410339A4
(en)
*
|
2021-12-14 |
2025-09-10 |
Daikin Ind Ltd |
SPRAYING DEVICE AND AIR TREATMENT DEVICE
|
|
AU2023228095A1
(en)
|
2022-03-02 |
2024-08-15 |
Horizon Therapeutics Ireland Dac |
Process of making a crystalline edg-2 receptor antagonist
|